Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

79-57-2

Oxytetracycline

79-57-2
132539-06-1

Olanzapine

132539-06-1
113617-63-3

Orbifloxacin

113617-63-3
3922-90-5

Oleandomycin

3922-90-5
32619-42-4

Oleuropein

32619-42-4
135308-74-6

O,N-Didesmethylvenlafaxin

135308-74-6
93413-62-8

O-Desmethylvenlafaxin

93413-62-8
204255-11-8

Oseltamivir Phosphate

204255-11-8
28721-07-5

Oxcarbamazepin

28721-07-5
2465-59-0

Oxipurinol

2465-59-0
14206-58-7

Oxytetracycline-4-epi

14206-58-7
7240-38-2

Oxacillin sodium salt hydrate

7240-38-2
1219170-21-4

Ofloxacin D8

1219170-21-4
6981-18-6

Ormetoprim

6981-18-6
73590-58-6

Omeprazole

73590-58-6
16837-52-8

Oxymatrine

16837-52-8
76-42-6

Oxycodone

76-42-6
2277-92-1

Oxyclozanide

2277-92-1
144689-24-7

Olmesartan

144689-24-7
315-72-0

Opipramol

315-72-0